$MDT - Primed for the next leg upNYSE:MDT broke out from the channel and is consolidating in a flag. It looks primed for the next leg up. 🚀
Price targets:
$92
$96
$100
$104
Downside risk:
$76
Key stats
About MEDTRONIC PLC CEDEAR EACH 4 REP 1
Sector
Industry
CEO
Geoffrey Straub Martha
Website
Headquarters
Dublin
Founded
2014
ISIN
ARDEUT111283
FIGI
BBG000HFXTS7
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Stocks pairs trading: BMY vs MDTIn the medical device and pharmaceutical sectors, contrasting financial metrics and market dynamics between Medtronic plc (MDT) and Bristol-Myers Squibb Company (BMY) present a compelling scenario for investors. Based on their respective financial performances and market positions, it could be strat
MDT Medtronic plc Options Ahead of EarningsIf you haven`t bought the previous dip in MDT:
Then analyzing the options chain and the chart patterns of MDT Medtronic plc prior to the earnings report this week,
I would consider purchasing the 75usd strike price at the money Calls with
an expiration date of 2023-11-24,
for a premium of approxim
i.Wish $MDT keep going down furtherMDT has increased its dividend for 46 consecutive years. Easing supply-chain issues, new product launches, and higher demand for medical procedures have been supporting Medtronic’s performance.
In addition, the company is focusing on digital technology adoption and cost-saving measures, with a targ
$MDT - Can 200DMA provide a support?NYSE:MDT Ouch! A false break out and a fast breakdown. Lets see if 200DMA can provide some support. Otherwise, a trip down to $76 is possible. ER is on 22nd August. Its a make it or break it quarter. 👀
Argus Market Mover on 06/20/2023: MDTcopy & paste directly from Argus,
Medtronic is one of the world's largest medical technology and solutions companies. The company’s devices focus on cardiac rhythm management, spinal and surgical navigation technologies, treatments
for diabetes and neurological conditions, vascular therapies, and
$MDT - Looks goodNYSE:MDT Breaking out of the descending wedge with a ☕️.
If the stock can break above $92, it can run to $105. Breaking below $84 would be bearish. $89 - 92 is going to be a hard resistance to overcome.
Targets - $92, $100, $105
Downside risk - $76
$MDT with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:MDT after a negative over reaction following its earnings release placing the stock in drift D with an expected accuracy of 40%.
Campaign Trading Medtronic to the $130 zoneyep ... Medtronic has been taking advantage of A.I. for years.
"By harnessing the power of AI, data analytics, and sensors, Medtronic's healthcare technologies are helping clinicians create individualized treatment plans to achieve better outcomes for more people in more places. From the world’s fi
MDT is set to recover - overreaction on the outlookMDT beat analysts' estimates but guided somewhat dovish. The market has penalized the stock - it could be an overreaction. The management executes well on the business. I expect higher prices.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
